Unlocking Drug-Free Futures: Finnish Study Reveals Immune System's Role in Halting Blood Cancer Medication

The picture shows healthy red and white blood cells. (Image: Mostphotos)

Researchers from the University of Helsinki, HUS Helsinki University Hospital, and Aalto University have published a breakthrough study revealing that a robust immune response may allow chronic myeloid leukemia (CML) patients to safely discontinue their medication. The study, funded by several Finnish foundations and part of the iCAN Digital Precision Cancer Medicine Flagship, showed that patients with higher levels of natural killer cells and T cells were more successful in stopping treatment. This discovery paves the way for combination therapies that could activate the immune system, potentially offering a medication-free life to a larger group of CML patients. The findings are a beacon of hope, suggesting that fortifying the immune system could be key to conquering not just CML but other cancers as well.

Thinking of making a move to Nordics?
Move within Nordics? Study in Nordics?
Hire in Nordics?

While we're busy getting our platform ready for everyone,
here's what you can do to stay connected and be in the loop.

Join Waitlist!

Joining is a commitment to innovation, a passion for tech, and the thrill of being the pioneer. Be among the first to embark on this journey and earn your "Nordic Pioneer" badge.

Check the News

Our news section isn't just a regular blog; it's the heartbeat of the Nordic tech ecosystem. Discover the driving forces behind the scene, from groundbreaking startups to cutting-edge research from top-tier universities.

Fill Our Survey

Moving to a new place or switching job paths is more than just a whim; it's a series of calculated decisions influenced by numerous factors. Help us understand your aspirations, challenges, and motivators.

Follow on Social Media

Our social media channels serve hot trends, insights, and announcements straight from the oven. Engage with us; we promise we're not just another brand. We listen, we share, we celebrate together.